Mobile Menu

Search Results

Search results for: Community

Ethical Piece: Eugenics and Where to Draw The Line

It all comes down to what decision is being made based upon a person’s genetics.

Interview with Dr Luigi Grassi, Informatics Scientist, AstraZeneca

I’m Luigi Grassi and I’m an Informatics Scientist at AstraZeneca. I’m responsible for designing and performing bioinformatical analyses of the […]

New diagnostic for Coronavirus receives CE mark

Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.

FDA releases list of evidence-based pharmacogenetic variants

Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.

WGS – The future of consumer genomics

With the falling cost of genome sequencing, it comes as no surprise that there is a growing interest in expanding the availability and accessibility of genomics via consumer testing. Now, Nebula Genomics has entered the market by launching a comprehensive at-home test that analyses the whole genome for just $299.

Foundations for AI are “Critical” to our Continued Success – Interview with Dr Paul Agapow, AstraZeneca

FLG: Can you introduce yourself and your work? I am currently a Health Informatics Director at AstraZeneca. I started my […]

Coming of age? How to translate generation genome into clinical practice

Karen Lighting Jones, Head of Future Place at Roche. Back in 2016, Dame Sally Davies concluded her Chief Medical Officer annual report by saying “Genomics is not tomorrow, it’s here today. I believe genomic services should be available to more patients, whilst being a cost-effective service in the NHS”.